Knight Frank has forecast an increase in lab and office demand across the UK, owing to a boost in venture capital funding for the pharma and biotech sectors.
According to the consultancy, the UK now accounts for 5% of global
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
